SCHEMBL9434751

SCHEMBL9434751

CC1=C(C(=O)O)N=c2c1c(C)c1c(c2-c2cccc(N(C)C)c2)-c2ccccc2N=1.CC1=C(C(=O)Oc2cccnc2)N=c2cc3c(c(C)c21)=Nc1ccccc1-3

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.33
TDP2 O95551 1/20 0.32
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8910149 0.82 KMT2A (0.42) POLBTDP2KMT2A
SCHEMBL8910407 0.81 BCHE (0.39) KMT2A
SCHEMBL8142537 0.73 MYC (0.34) KMT2A
SCHEMBL8148024 0.71 TDP2 (0.40) POLBTDP2KMT2A
SCHEMBL8155023 0.69 HTT (0.33) KMT2A
SCHEMBL9057850 0.68 MYC (0.36)
SCHEMBL8910285 0.67 PARP10 (0.44) POLBKMT2A
SCHEMBL8909858 0.66 MAPT (0.30) KMT2A
SCHEMBL8910147 0.66 LMNA (0.31)
SCHEMBL8153428 0.65 TP53 (0.36) POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed